Search results for "Bioavailability"

showing 10 items of 301 documents

Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.

1994

Several studies have been carried out to elucidate the causes of the low oral bioavailability of amoxicillin in rats. The hepatic first-pass effect of the antibiotic was estimated by comparing the area under the plasma drug concentration-versus-time curve from time zero to infinity (AUC0-infinity) obtained after injecting the drug into a mesenteric vein with the AUC0-infinity value obtained after injecting the drug into the jugular vein of conscious rats. No hepatic first-pass effect was detected. The bioavailability of amoxicillin after intraduodenal administration was only 51%, and the fraction of the dose remaining in the intestine at the end of the experiment was 4.5%. This was far less…

Malemedicine.medical_specialtyAdministration OralBiological AvailabilityIntestinal absorptionFirst pass effectPharmacokineticsOral administrationInternal medicinemedicineAnimalsPharmacology (medical)Intestinal MucosaRats WistarAntibacterial agentPharmacologybusiness.industryHalf-lifeAmoxicillinAmoxicillinBioavailabilityRatsInfectious DiseasesEndocrinologyIntestinal AbsorptionLiverbusinessmedicine.drugResearch ArticleHalf-Life
researchProduct

Pharmacokinetics and bioavailability of diclofenac in the rat.

1991

Diclofenac sodium is a widely used drug with interesting absorption and disposition features when administered to laboratory animals. The present study was undertaken to assess the pharmacokinetics of the drug after iv and gastrointestinal dosing to rats. Renal excretion of unchanged drug was negligible, but biliary excretion of the drug (unchanged and conjugated) was detected in bile duct-cannulated rats; it accounted for 27.2 and 31.2% of the total dose following iv and intraduodenal administration, respectively. Most of the drug excreted in the bile was conjugated diclofenac; unchanged drug accounted for only 4.7 and 5.4% of total diclofenac excreted in the bile after iv and intraduodena…

Malemedicine.medical_specialtyDiclofenacDuodenumAdministration OralBiological AvailabilityPharmacologyIntestinal absorptionInjectionsDiclofenacPharmacokineticsOral administrationInternal medicinemedicineAnimalsBilePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsEnterohepatic circulationChemistryRats Inbred StrainsDiclofenac SodiumBioavailabilityRatsstomatognathic diseasesmedicine.anatomical_structureEndocrinologyIntestinal AbsorptionData Interpretation StatisticalInjections IntravenousDuodenummedicine.drugJournal of pharmacokinetics and biopharmaceutics
researchProduct

The influence of active secretion processes on intestinal absorption of salbutamol in the rat.

2001

Abstract Salbutamol was perfused in the small intestine of rat using a standard rat gut ‘in situ’ preparation: (1) in inhibitor-free solution at seven different concentrations (0.15, 0.29, 1.20, 5.0, 9.0, 13.0 and 18.0 mM); (2) at a 0.29 mM concentration – thought to be close to the allometric dose in man – in the presence of a non-specific enzyme inhibitor, sodium azide (0.3, 3.0 and 6.0 mM); and (3) at 0.29 mM in the presence of a selective secretion inhibitor, verapamil (10.0 and 20.0 mM). In free solution, the mixed-order rate constants, k ′ a , of salbutamol increase as the solute concentration increases until an apparent asymptotic value is reached. This could be due to the saturation…

Malemedicine.medical_specialtyEnterocytePharmaceutical ScienceIntestinal absorptionchemistry.chemical_compoundInternal medicinemedicineAnimalsAlbuterolATP Binding Cassette Transporter Subfamily B Member 1Rats WistarSodium AzidebiologyDose-Response Relationship DrugChemistryGeneral MedicineAdrenergic beta-AgonistsSmall intestineBioavailabilityRatsEndocrinologymedicine.anatomical_structureIntestinal AbsorptionVerapamilEnzyme inhibitorSalbutamolbiology.proteinVerapamilSodium azideBiotechnologymedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Hepatic extraction of isosorbide dinitrate in cardiac patients

1983

Hepatic extraction of organic nitrates, including that of isosorbide dinitrate (ISDN), has been thought to be nearly complete in man but has never been directly measured. We examined the time course of plasma ISDN and metabolite concentrations in arterial and hepatic venous blood in four cardiac patients receiving an intravenous ISDN infusion. Apparent hepatic extraction of ISDN was high (90%) at the beginning of infusion but fell to about 44% 1 hr after termination of infusion. The decrease in ISDN concentration gradient across the liver correlates with an increase in plasma isosorbide-5-mononitrate concentration, but a cause-and-effect relationship resulting from metabolite inhibition can…

Malemedicine.medical_specialtyMetaboliteBiological AvailabilityCoronary DiseaseIsosorbide DinitratePharmacologylaw.inventionchemistry.chemical_compoundlawInternal medicineHepatic extractionmedicineHumansInfusions ParenteralPharmacology (medical)In patientPharmacologyClinical pharmacologybusiness.industryVenous bloodMiddle AgedBioavailabilityKineticsEndocrinologyLiverchemistryTime courseIsosorbide dinitratebusinessmedicine.drugClinical Pharmacology and Therapeutics
researchProduct

Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bil…

2011

Abstract Nevirapine is a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1. The usual dosing regimen is 200 mg twice/day. Reducing the dosing frequency would significantly improve treatment adherence and quality of life of patients. To study new forms of administration, it is necessary to do pre-clinical studies and know the absorption characteristics of nevirapine in laboratory animals. However, there are no studies about its bioavailability in rats and hardly any about its pharmacokinetic. The objectives of this study were to describe the pharmacokinetics of nevirapine in rats after intravenous, oral and subcutaneous administration, to assess its absorp…

Malemedicine.medical_specialtyNevirapineDuodenumInjections SubcutaneousPharmaceutical ScienceAdministration OralBiological AvailabilityIleumAbsorption (skin)PharmacologyGastroenterologyIntestinal absorptionPharmacokineticsSpecies SpecificityOral administrationInternal medicinemedicineAnimalsBileHumansNevirapineRats Wistarbusiness.industrydigestive oral and skin physiologyBioavailabilityRatsGastrointestinal Tractmedicine.anatomical_structureIntestinal AbsorptionInjections IntravenousDuodenumReverse Transcriptase Inhibitorsbusinessmedicine.drugInternational journal of pharmaceutics
researchProduct

Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity Studies

2007

This article describes the development of nanostructured lipid carriers (NLC) as colloidal carriers for two antitumor compounds that possess a remarkable antineoplastic activity. But their limited stability and low solubility in water could give a very low parenteral bioavailability. Results revealed an enhancement of the cytotoxicity effect of drug-loaded NLC on human prostate cancer (PC-3) and human hepatocellular carcinoma (HuH-6, HuH-7) cell lines with respect to that of both free drugs. Results of characterization studies strongly support the potential application of these drugs-loaded NLC as prolonged delivery systems for lipophilic drugs by several administration routes, in particula…

Materials scienceCell SurvivalDrug CompoundingPharmaceutical ScienceNanoparticleAntineoplastic AgentsPharmacologynanostructured lipid carrierHuman prostatehuman prostate carcinoma cellPlasmaCell Line TumorElectrochemistryHumansParticle SizeSolubilityCytotoxicityChromatography High Pressure LiquidDrug CarriersGeneral Medicineantitumor drugLipidsControlled releaseBioavailabilitySolubilityPlasma chemistryNanoparticleshuman hepatocellular carcinoma cellcontrolled releaseDrug metabolism
researchProduct

Evaluation of Silver Ion Bioavailability from Silver Doped Hydroxyapatite

2014

Thein vitrobehavior of silver doped hydroxyapatite (HAp/Ag) prepared by two wet precipitation routes were studied in water and simulated body fluid (SBF). In order to evaluate the silver ion bioavailability from HAp/Ag, the samples were soaked in SBF or water and kept at 37°C for fixed periods of time up to one year. After fixed periods of time, analyses of SBF and water solutions were performed and silver ion concentration within the solutions determined. According to silver release data from dense and porous HAp/Ag ceramic scaffolds, release rate of silver ions were reduced in water as the ion exchange there was slower compared to SBF solution. X-ray diffraction and scanning electron micr…

Materials scienceIon exchangeScanning electron microscopePrecipitation (chemistry)Mechanical EngineeringSimulated body fluidMineralogyBioavailabilityIonMechanics of Materialsvisual_artvisual_art.visual_art_mediumGeneral Materials ScienceCeramicPorosityNuclear chemistryKey Engineering Materials
researchProduct

Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.

2001

Polyethyleneglycol (PEG)-coated polyethylcyanoacrylate (PECA) nanoparticles loaded with amoxicillin were prepared and the influence of the PEG coating on the particle size, zeta potential, drug release rate and phagocytic uptake by murine macrophages was studied. Experimental results show that this colloidal drug delivery system could be useful for intravenous or oral administration. The profile of amoxicillin release from PECA nanoparticles system was studied under various conditions similar to those of some corporeal fluids. In all these experiments, amoxicillin release in the free form was studied by HPLC analysis. Experimental results showed that at pH 7.4 drug release rises when molecu…

Materials sciencePhagocytosisBiophysicsNanoparticleBioengineeringBiocompatible MaterialsIn Vitro TechniquesPolyethylene GlycolsBiomaterialsMiceDrug Delivery SystemsDrug StabilityPhagocytosisOral administrationPEG ratioZeta potentialAnimalsHumansCyanoacrylatesParticle SizeChromatographyMacrophagesAmoxicillinHydrogen-Ion ConcentrationUreaseMicrospheresBioavailabilityBiochemistryMechanics of MaterialsDrug deliveryCeramics and CompositesParticle sizeBiomaterials
researchProduct

Medroxyprogesterone acetate: steady-state pharmacokinetics bioequivalence of two oral formulations

1989

Two micronized oral formulations of medroxyprogesterone acetate (MPA) (Farlutal and Clinovir) were compared in order to evaluate their relative bioavailability. Sixteen female patients with metastatic breast cancer were entered in a randomized cross-over study on 500-mg MPA tablets repeatedly administered (twice daily for 20 days). At the steady state, similar mean +/- SD serum levels of MPA were obtained (131 +/- 44 ng/ml for Farlutal and 136 +/- 45 ng/ml for Clinovir) and the two formulations proved to be bioequivalent (confidence interval at a significance level of 0.95 = 93%-107%).

MedroxyprogesteroneCancer Researchbusiness.industryMedroxyprogesteroneAdministration OralAntineoplastic AgentsMedroxyprogesterone AcetateGeneral MedicineMiddle AgedPharmacologyBioequivalenceConfidence intervalDosage formBioavailabilityTherapeutic EquivalencyOncologyPharmacokineticsOral administrationHumansMedicineMedroxyprogesterone acetateFemalebusinessmedicine.drugJournal of Cancer Research and Clinical Oncology
researchProduct

Phenolic and microbial-targeted metabolomics to discovering and evaluating wine intake biomarkers in human urine and plasma

2014

The discovery of biomarkers of intake in nutritional epidemiological studies is essential in establishing an association between dietary intake (considering their bioavailability) and diet-related risk factors for diseases. The aim is to study urine and plasma phenolic and microbial profile by targeted metabolomics approach in a wine intervention clinical trial for discovering and evaluating food intake biomarkers. High-risk male volunteers (n = 36) were included in a randomized, crossover intervention clinical trial. After a washout period, subjects received red wine or gin, or dealcoholized red wine over four weeks. Fasting plasma and 24-h urine were collected at baseline and after each i…

MetaboliteClinical BiochemistryWineUrineUrineBlood plasmaBiochemistryAnalytical Chemistrychemistry.chemical_compoundMetabolomicsMetabolitesViGallic acidFood scienceDietoteràpiaWineChromatographyBiochemical markersDiet therapyArea under the curvePlasma sanguiniStepwise regressionMetabòlitsOrinaBioavailabilitychemistryMarcadors bioquímics
researchProduct